Engineers grow functioning human muscle from skin cellsJanuary 09, 2018
DURHAM, N.C. -- Biomedical engineers have grown the first functioning human skeletal muscle from induced pluripotent stem cells.
The advance builds on work published in 2015 when researchers at Duke University grew the first functioning human muscle tissue from cells obtained from muscle biopsies. The ability to start from cellular scratch using non-muscle tissue will allow scientists to grow far more muscle cells, provide an easier path to genome editing and cellular therapies, and develop individually tailored models of rare muscle diseases for drug discovery and basic biology studies.
The results appear online Tuesday, January 9, in Nature Communications.
"Starting with pluripotent stem cells that are not muscle cells, but can become all existing cells in our body, allows us to grow an unlimited number of myogenic progenitor cells," said Nenad Bursac, professor of biomedical engineering at Duke University. "These progenitor cells resemble adult muscle stem cells called 'satellite cells' that can theoretically grow an entire muscle starting from a single cell."
In their previous work, Bursac and his team started with small samples of human cells obtained from muscle biopsies, called "myoblasts," that had already progressed beyond the stem cell stage but hadn't yet become mature muscle fibers. They grew these myoblasts by many folds and then put them into a supportive 3-D scaffolding filled with a nourishing gel that allowed them to form aligned and functioning human muscle fibers.
In the new study, the researchers instead started with human induced pluripotent stem cells. These are cells taken from adult non-muscle tissues, such as skin or blood, and reprogrammed to revert to a primordial state. The pluripotent stem cells are then grown while being flooded with a molecule called Pax7 -- which signals the cells to start becoming muscle.
As the cells proliferated they became very similar to --but not quite as robust as -- adult muscle stem cells. While previous studies had accomplished this feat, nobody has been able to then grow these intermediate cells into functioning skeletal muscle.
The Duke researchers succeeded where previous attempts had failed.
"It's taken years of trial and error, making educated guesses and taking baby steps to finally produce functioning human muscle from pluripotent stem cells," said Lingjun Rao, a postdoctoral researcher in Bursac's laboratory and first author of the study. "What made the difference are our unique cell culture conditions and 3-D matrix, which allowed cells to grow and develop much faster and longer than the 2-D culture approaches that are more typically used."
Once the cells were well on their way to becoming muscle, Bursac and Rao stopped providing the Pax7 signaling molecule and started giving the cells the support and nourishment they needed to fully mature.
In the study, the researchers show that after two to four weeks of 3-D culture, the resulting muscle cells form muscle fibers that contract and react to external stimuli such as electrical pulses and biochemical signals mimicking neuronal inputs just like native muscle tissue. They also implanted the newly grown muscle fibers into adult mice and showed that they survive and function for at least three weeks while progressively integrating into the native tissue through vascularization.
The resulting muscle, however, is not as strong as native muscle tissue, and also falls short of the muscle grown in the previous study that started from muscle biopsies. Despite this caveat, the researchers say this muscle still holds potential that the stronger, older relative does not.
The pluripotent stem cell-derived muscle fibers develop reservoirs of "satellite-like cells" that are necessary for normal adult muscles to repair damage, while the muscle from the previous study had much fewer of these cells. The stem cell method is also capable of growing many more cells from a smaller starting batch than the biopsy method.
Both of the advantages point toward a possibility of using this new method for regenerative therapies and for creating models of rare diseases for future studies and individualized health care.
"The prospect of studying rare diseases is especially exciting for us," said Bursac. "When a child's muscles are already withering away from something like Duchenne muscular dystrophy, it would not be ethical to take muscle samples from them and do further damage. But with this technique, we can just take a small sample of non-muscle tissue, like skin or blood, revert the obtained cells to a pluripotent state, and eventually grow an endless amount of functioning muscle fibers to test."
The technique also holds promise for being combined with genetic therapies. Researchers could, in theory, fix genetic malfunctions in the induced pluripotent stem cells derived from a patient and then grow small patches of completely healthy muscle. While this could not heal or replace an entire body's worth of diseased muscle, it could be used in tandem with more widely targeted genetic therapies or to heal more localized problems.
The researchers are now refining their technique to grow more robust muscles and beginning work to develop new models of rare muscle diseases.
CITATION: "Engineering Human Pluripotent Stem Cells Into a Functional Skeletal Muscle Tissue." Lingjun Rao, Ying Qian, Alastair Khodabukus, Thomas Ribar and Nenad Bursac. Nature Communications, January 2018. DOI: 10.1038/s41467-017-02636-4
Related Pluripotent Stem Cells Articles:
Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery.
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
Boston University scientists have announced two major findings that further our understanding of how stem cells become organs: the ability to grow and purify the earliest lung progenitors that emerge from human stem cells, and the ability to differentiate these cells into tiny 'bronchospheres' that model cystic fibrosis.
Despite immense promise, adoption of induced pluripotent stem cells (iPSCs) in biomedical research and medicine has been slowed by concerns that these cells are prone to increased numbers of genetic mutations.
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Researchers from the Institute for Stem Cell Research and Regenerative Medicine at the University Clinic of Düsseldorf have established an in vitro model system for investigating nonalcoholic fatty liver disease (NAFLD).
Researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts, led by Jonathan Garlick, have established for the first time that skin cells from diabetic foot ulcers can be reprogrammed to acquire properties of embryonic-like cells.
As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use.
Related Pluripotent Stem Cells Reading:
Atlas of Human Pluripotent Stem Cells in Culture
by Lyn Healy (Author), Ludmila Ruban (Author)
This lavishly-illustrated, authoritative atlas explores the intricate art of culturing human pluripotent stem cells. Twelve chapters – containing more than 280 color illustrations – cover a variety of topics in pluripotent stem cell culturing including mouse and human fibroblasts, human embryonic stem cells and induced pluripotent stem cells, characteristic staining patterns, and abnormal cultures, among others. Atlas of Human Pluripotent Stem Cells in Culture is a comprehensive collection of illustrated techniques complemented by informative and educational captions examining... View Details
Induced pluripotent stem cells: Production and utility in regenerative medicine and other applications (Euroscicon Meeting Report)
The 4th annual “Induced pluripotent stem cells” meeting, organized by EuroSciCon, was part of the 2013 Stem Cell Trilogy Event. The main topics of the conference included: human iPS cells with emphasis on the clinical applications, tissue engineering and regenerative medicine.
The first session of the meeting was chaired by Dr. Lyn Healy, who has more than 20 years of experience in the stem cell field and holds a position as senior Stem Cell Biologist at the UK Stem Cell Bank (National Institute for Biological Standards and Control, UK). An interesting aspect of the sessions... View Details
Induced Pluripotent Stem (iPS) Cells: Methods and Protocols (Methods in Molecular Biology)
by Kursad Turksen (Editor), Andras Nagy (Editor)
This volume aims to be a collection of essential protocols in iPS cell field. Induced Pluripotent Stem (iPS) Cells: Methods and Protocols guides readers through multiple facets of stem cell biology, lineage commitment and differentiation. Written for the Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and practical, Induced... View Details
Multipotent Stem Cells of the Hair Follicle: Methods and Protocols (Methods in Molecular Biology)
by Robert M Hoffman (Editor)
This volume discusses methods for the study of multipotent and pluripotent stem cells of the hair follicle. The stem cells described are involved in both the growth of the hair follicle and its production of the hair shaft, as well as the growth of the hair follicle sensory nerve. Multipotent Stem Cells of the Hair Follicle: Methods and Protocols also explores very unexpected results such as that of the hair follicle-associated-pluripotent (HAP) stem cells, which not only have the capability for regenerating the hair follicle sensory nerve, but also can differentiate ex vivo and in... View Details
Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization (Methods in Molecular Biology)
by Andras Nagy (Editor), Kursad Turksen (Editor)
This volume captures the rapid developments in the field of induced pluripotent stem (iPS) cells, which have provided novel opportunities and approaches both for better understanding a number of human diseases and for developing new platforms for drug development and screening for such diseases. Specifically, representative protocols on various disease models have been collected from labs around the world. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents,... View Details
Atlas of Human Pluripotent Stem Cells: Derivation and Culturing (Stem Cell Biology and Regenerative Medicine)
by Michal Amit (Editor), Joseph Itskovitz-Eldor (Editor)
Human pluripotent stem cells, including human embryonic stem cells and induced pluripotent stem cells, are a key focus of current biomedical research. The emergence of state of the art culturing techniques is promoting the realization of the full potential of pluripotent stem cells in basic and translational research and in cell-based therapies. This comprehensive and authoritative atlas summarizes more than a decade of experience accumulated by a leading research team in this field. Hands-on step-by-step guidance for the derivation and culturing of human pluripotent stem cells in defined... View Details
Human Pluripotent Stem Cells: Methods and Protocols (Methods in Molecular Biology)
by Philip H. Schwartz (Editor), Robin L. Wesselschmidt (Editor)
Almost daily, new technologies are being presented that move the field of human pluripotent stem cell research towards a future that may yield highly-effective, personalized medical treatments. Three enabling technologies at hand for human PSCs are 1) directed reprogramming of somatic cells, which eliminate many of the ethical issues associated with the derivation and use of human PSCs, increase genetic diversity of the available human PSC lines, and give rise to better in vitro human disease models; 2) the discovery that a Rho-associated protein Kinase (ROCK) inhibitor allows for... View Details
Pluripotent Stem Cells: Methods and Protocols (Methods in Molecular Biology)
by Uma Lakshmipathy (Editor), Mohan C Vemuri (Editor)
Human pluripotent stem cells such as human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) with their unique developmental plasticity hold immense potential as cellular models for drug discovery and in regenerative medicine as a source for cell replacement. While hESC are derived from a developing embryo, iPSC are generated with forced expression of key transcription factors to convert adult somatic cells to ESC-like cells, a process termed reprogramming. Using iPSC overcomes ethical issues concerning the use of developing embryos and it can be generated from... View Details
Pluripotent Stem Cells (Stem Cells - Laboratory and Clinical Research)
by Derek W. Rosales (Author), Derek W. Rosales (Editor), Quentin N. Mullen (Editor)
Pluripotent cells of the early embryo originate all types of somatic cells and germ cells of adult organism. This book examines the fundamental mechanisms which regulate normal development of pluripotent cells into different lineages and are disrupted in cancer initiating cells. View Details
Pluripotent Stem Cells: Current Researches
by Jack Collins (Editor)
This book is an up-to-date guide on pluripotent stem cells. Several types of stem cells are being examined for their regenerative ability. Stem cells have developed a great amount of excitement among the clinicians, researchers and the public alike. Slight advantage because of transplanting autologous stem cells in several distinct clinical conditions has been suggested to be a progress factor effect rather than actual regeneration. In comparison, several pre-clinical analyses have been carried out, with the help of differentiated cells from induced pluripotent stem cells or embryonic stem... View Details